BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20628049)

  • 21. Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy.
    Thomas J; Sairoz ; Jose A; Poojari VG; Shetty S; K SP; Prabhu R V K; Rao M
    Reprod Sci; 2023 Jun; 30(6):1758-1769. PubMed ID: 36595209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone transporters.
    Friesema EC; Jansen J; Milici C; Visser TJ
    Vitam Horm; 2005; 70():137-67. PubMed ID: 15727804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
    Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
    Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain.
    De Angelis M; Maity-Kumar G; Schriever SC; Kozlova EV; Müller TD; Pfluger PT; Curras-Collazo MC; Schramm KW
    J Pharm Biomed Anal; 2022 Nov; 221():115038. PubMed ID: 36152487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CRISPR/Cas9-engineered avatar mouse model of monocarboxylate transporter 8 deficiency displays distinct neurological alterations.
    Valcárcel-Hernández V; Guillén-Yunta M; Bueno-Arribas M; Montero-Pedrazuela A; Grijota-Martínez C; Markossian S; García-Aldea Á; Flamant F; Bárez-López S; Guadaño-Ferraz A
    Neurobiol Dis; 2022 Nov; 174():105896. PubMed ID: 36243247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
    JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations.
    Fischer J; Kleinau G; Müller A; Kühnen P; Zwanziger D; Kinne A; Rehders M; Moeller LC; Führer D; Grüters A; Krude H; Brix K; Biebermann H
    J Mol Endocrinol; 2015 Feb; 54(1):39-50. PubMed ID: 25527620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct Actions of the Thyroid Hormone Transporters Mct8 and Oatp1c1 in Murine Adult Hippocampal Neurogenesis.
    Mayerl S; Alcaide Martin A; Bauer R; Schwaninger M; Heuer H; Ffrench-Constant C
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development.
    Vancamp P; Darras VM
    Gen Comp Endocrinol; 2018 Sep; 265():219-229. PubMed ID: 29183795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
    Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
    Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
    [No Abstract]   [Full Text] [Related]  

  • 34. Thyroid hormone transport in and out of cells.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Trends Endocrinol Metab; 2008 Mar; 19(2):50-6. PubMed ID: 18291666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters.
    van der Deure WM; Peeters RP; Visser TJ
    J Mol Endocrinol; 2010 Jan; 44(1):1-11. PubMed ID: 19541799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid Hormone Transporters.
    Groeneweg S; van Geest FS; Peeters RP; Heuer H; Visser WE
    Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31754699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zebrafish as a model for monocarboxyl transporter 8-deficiency.
    Vatine GD; Zada D; Lerer-Goldshtein T; Tovin A; Malkinson G; Yaniv K; Appelbaum L
    J Biol Chem; 2013 Jan; 288(1):169-80. PubMed ID: 23161551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights on the role of thyroid hormone transport in neurosensory organs and implication for the Allan-Herndon-Dudley syndrome.
    García-Aldea Á; Guillén-Yunta M; Valcárcel-Hernández V; Montero-Pedrazuela A; Guadaño-Ferraz A; Bárez-López S
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38417253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.